Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Human dopamine transporter gene variation: effects of protein coding variants V55A and V382A on expression and uptake activities

The Pharmacogenomics Journal volume 3, pages 159–168 (2003)Cite this article

ABSTRACT

The human dopamine transporter (DAT, SLC6A3) is an important 15 exon gene for dopamine neurotransmission and dopamine recycling. Common exon 15 variable number tandem repeat variants can be associated with attention deficit/hyperactivity disorder. Rarer single nucleotide polymorphisms produce missense variants including V55A and V382A. We now report studies of the functional influences of these DAT protein-coding variants. In COS cell transient-expression assays, V382A displays about half of the dopamine uptake velocity Vmax and cocaine analog binding Bmax values of wildtype DAT. V382A lowers dopamine's potency in inhibiting cocaine analog binding by six-fold. Cells expressing V382A or mixtures of V382A and wildtype DAT both display reduced plasma membrane and increased perinuclear expression, consistent with dominant effects of V328A on expression. V55A expresses normally but reveals a 1.7-fold-lower Km for dopamine uptake. Individuals with these human DAT protein variants could display altered dopamine systems.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG . Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 1996; 379: 606–612.

    Article  CAS  Google Scholar 

  2. Wisor JP, Nishino S, Sora I, Uhl GR, Mignot E, Edgar DM . Dopaminergic role in stimulant-induced wakefulness. J Neurosci 2001; 21: 1787–1794.

    Article  CAS  Google Scholar 

  3. Sora I, Hall FS, Andrews AM, Itokawa M, Li XF, Wei HB et al. Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. Proc Natl Acad Sci USA 2001; 98: 5300–5305.

    Article  CAS  Google Scholar 

  4. Vandenbergh DJ, Persico AM, Uhl GR . A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic TaqI RFLPs. Brain Res Mol Brain Res 1992; 15: 161–166.

    Article  CAS  Google Scholar 

  5. Varrone A, Marek KL, Jennings D, Innis RB, Seibyl JP . [(123)I]beta-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy. Mov Disord 2001; 16: 1023–1032.

    Article  CAS  Google Scholar 

  6. Parkinson Study Group. A multicenter assessment of dopamine transporter imaging with DOPASCAN/SPECT in parkinsonism. Neurology 2000; 28: 1540–1547.

  7. Miller GM, De La Garza II RD, Novak MA, Madras BK . Single nucleotide polymorphisms distinguish multiple dopamine transporter alleles in primates: implications for association with attention deficit hyperactivity disorder and other neuropsychiatric disorders. Mol Psychiatry 2001; 6: 50–58.

    Article  CAS  Google Scholar 

  8. Krause KH, Dresel SH, Krause J, Kung HF, Tatsch K . Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography. Neurosci Lett 2000; 285: 107–110.

    Article  CAS  Google Scholar 

  9. Kelsoe JR, Sadovnick AD, Kristbjarnarson H, Bergesch P, Mroczkowski-Parker Z, Drennan M et al. Possible locus for bipolar disorder near the dopamine transporter on chromosome 5. Am J Med Genet 1996; 67: 533–540.

    Article  CAS  Google Scholar 

  10. Greenwood TA, Alexander M, Keck PE, McElroy S, Sadovnick AD, Remick RA et al. Evidence for linkage disequilibrium between the dopamine transporter and bipolar disorder. Am J Med Genet 2001; 105: 145–151.

    Article  CAS  Google Scholar 

  11. Laakso A, Bergman J, Haaparanta M, Vilkman H, Solin O, Syvalahti E et al. Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia. Schizophr Res 2001; 52: 115–120.

    Article  CAS  Google Scholar 

  12. Inada T, Sugita T, Dobashi I, Inagaki A, Kitao Y, Matsuda G et al. Dopamine transporter gene polymorphism and psychiatric symptoms seen in schizophrenic patients at their first episode. Am J Med Genet 1996; 67: 406–408.

    Article  CAS  Google Scholar 

  13. Maier W, Minges J, Eckstein N, Brodski C, Albus M, Lerer B et al. Genetic relationship between dopamine transporter gene and schizophrenia: linkage and association. Schizophr Res 1996; 20: 175–180.

    Article  CAS  Google Scholar 

  14. Laine TP, Ahonen A, Rasanen P, Tiihonen J . Dopamine transporter density and novelty seeking among alcoholics. J Addict Dis 2001; 20: 91–96.

    Article  CAS  Google Scholar 

  15. Yoshimoto K, Ueda S, Nishi M, Yang Y, Matsushita H, Takeuchi Y et al. Changes in dopamine transporter and c-Fos expression in the nucleus accumbens of alcohol-tolerant rats. Alcohol Clin Exp Res 2000; 24: 361–365.

    Article  CAS  Google Scholar 

  16. Uhl GR, Hall FS, Sora I . Cocaine, reward, movement and monoamine transporters. Mol Psychiatry 2002; 7: 21–26.

    Article  CAS  Google Scholar 

  17. McCann UD, Wong DF, Yokoi F, Villemagne V, Dannals RF, Ricaurte GA . Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428. J Neurosci 1998; 18: 8417–8422.

    Article  CAS  Google Scholar 

  18. Weber P, Lutschg J . Methylphenidate treatment. Pediatr Neurol 2002; 26: 261–266.

    Article  Google Scholar 

  19. Mitler MM, Shafor R, Hajdukovich R, Timms RM, Browman CP . Treatment of narcolepsy: objective studies on methylphenidate, pemoline, and protriptyline. Sleep 1986; 9: 260–264.

    Article  CAS  Google Scholar 

  20. Lin Z, Itokawa M, Uhl GR . Dopamine transporter proline mutations influence dopamine uptake, cocaine analog recognition, and expression. FASEB J 2000; 14: 715–728.

    Article  CAS  Google Scholar 

  21. Lin Z, Wang W, Kopajtic T, Revay RS, Uhl GR . Dopamine transporter: transmembrane phenylalanine mutations can selectively influence dopamine uptake and cocaine analog recognition. Mol Pharmacol 1999; 56: 434–447.

    Article  CAS  Google Scholar 

  22. Lin Z, Uhl GR . Dopamine transporter mutants with cocaine resistance and normal dopamine uptake provide targets for cocaine antagonism. Mol Pharmacol 2002; 61: 885–891.

    Article  CAS  Google Scholar 

  23. Itokawa M, Lin Z, Cai NS, Wu C, Kitayama S, Wang JB et al. Dopamine transporter transmembrane domain polar mutants: ΔG and ΔΔG values implicate regions important for transporter functions. Mol Pharmacol 2000; 5: 1093–1103.

    Google Scholar 

  24. Lin Z, Wang W, Uhl GR . Dopamine transporter tryptophan mutants highlight candidate dopamine- and cocaine-selective domains. Mol Pharmacol 2000; 58: 1581–1592.

    Article  CAS  Google Scholar 

  25. Chen N, Vaughan RA, Reith ME . The role of conserved tryptophan and acidic residues in the human dopamine transporter as characterized by site-directed mutagenesis. J Neurochem 2001; 77: 1116–1127.

    Article  CAS  Google Scholar 

  26. Vandenbergh DJ, Thompson MD, Cook EH, Bendahhou E, Nguyen T, Krasowski MD et al. Human dopamine transporter gene: coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populations. Mol Psychiatry 2000; 5: 283–292.

    Article  CAS  Google Scholar 

  27. Grunhage F, Schulze TG, Muller DJ, Lanczik M, Franzek E, Albus M et al. Systematic screening for DNA sequence variation in the coding region of the human dopamine transporter gene (DAT1). Mol Psychiatry 2000; 5: 275–282.

    Article  CAS  Google Scholar 

  28. Wang JB, Moriwaki A, Uhl GR . Dopamine transporter cysteine mutants: second extracellular loop cysteines are required for transporter expression. J Neurochem 1995; 64: 1416–1419.

    Article  CAS  Google Scholar 

  29. Hastrup H, Karlin A, Javitch JA . Symmetrical dimer of the human dopamine transporter revealed by cross-linking Cys-306 at the extracellular end of the sixth transmembrane segment. Proc Natl Acad Sci USA 2001; 98: 10055–10060.

    Article  CAS  Google Scholar 

  30. Bauer M, Meyer M, Grimm L, Meitinger T, Zimmer J, Gasser T et al. Nonviral glial cell-derived neurotrophic factor gene transfer enhances survival of cultured dopaminergic neurons and improves their function after transplantation in a rat model of Parkinson's disease. Hum Gene Ther 2000; 11: 1529–1541.

    Article  CAS  Google Scholar 

  31. Cheng Y–C, Prusoff WH . Relationships between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 1973; 22: 3099–3108.

    Article  CAS  Google Scholar 

  32. Vaughan RA, Uhl GR, Kuhar MJ . Recognition of dopamine transporters of antipeptide antibodies. Mol Cell Neurosci 1993; 4: 209–215.

    Article  CAS  Google Scholar 

  33. Vaughan RA, Huff RA, Uhl GR, Kuhar MJ . Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes. J Biol Chem 1997; 272: 15541–15546.

    Article  CAS  Google Scholar 

  34. Huff RA, Vaughan RA, Kuhar MJ, Uhl GR . Phorbol esters increase dopamine transporter phosphorylation and decrease transport Vmax . J Neurochem 1997; 68: 225–232.

    Article  CAS  Google Scholar 

  35. Vaughan RA, Kuhar MJ . Dopamine transporter ligand binding domains. Structural and functional properties revealed by limited proteolysis. J Biol Chem 1996; 271: 21672–22180.

    Article  CAS  Google Scholar 

  36. Nirenberg MJ, Chan J, Vaughan RA, Uhl GR, Kuhar MJ, Pickel VM . Immunogold localization of the dopamine transporter: an ultrastructural study of the rat ventral tegmental area. J Neurosci 1997; 17: 4037–4044.

    Article  CAS  Google Scholar 

  37. Donovan DM, Miner LL, Perry MP, Revay RS, Sharpe LG, Przedborski S et al. Cocaine reward and MPTP toxicity: alteration by regional variant dopamine transporter overexpression. Brain Res Mol Brain Res 1999; 73: 37–49.

    Article  CAS  Google Scholar 

  38. Sarkar G, Sommer SS . The ‘megaprimer’ method of site-directed mutagenesis. Biotechniques 1990; 8: 404–407.

    CAS  PubMed  Google Scholar 

  39. Pfenning MA, Richelson E . In: Yamamura HI, Enna SJ, Kuhar MJ (eds). Neurotransmitter Receptor Analysis. Raven Press: New York, 1990, pp 147–175.

    Google Scholar 

Download references

Acknowledgements

This work was supported financially by NIH/NIDA/IRP.

Author information

Authors and Affiliations

  1. Molecular Neurobiology Branch, NIDA-IRP, NIH, Nathan Shock Drive, Baltimore, MD, USA

    Zhicheng Lin & George R Uhl

Authors
  1. Zhicheng Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. George R Uhl
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to George R Uhl.

Additional information

DUALITY OF INTEREST

None declared.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lin, Z., Uhl, G. Human dopamine transporter gene variation: effects of protein coding variants V55A and V382A on expression and uptake activities. Pharmacogenomics J 3, 159–168 (2003). https://doi.org/10.1038/sj.tpj.6500169

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.tpj.6500169

Keywords

This article is cited by

Search

Advanced search

Quick links